adcortyl intra-articular / intradermal 50mg/5ml suspension for injection vials
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 10mg/1ml
kenalog intramuscular 80mg/2ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
kenalog intramuscular 40mg/1ml suspension for injection pre-filled syringes
bristol-myers squibb pharmaceuticals ltd - triamcinolone acetonide - suspension for injection - 40mg/1ml
nalorex 50mg tablets
bristol-myers squibb pharmaceuticals ltd - naltrexone hydrochloride - oral tablet - 50mg
azactam 1g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 1gram
azactam 2g powder for solution for injection vials
bristol-myers squibb pharmaceuticals ltd - aztreonam - powder for solution for injection - 2gram
videx 25mg chewable dispersible tablets
bristol-myers squibb pharmaceuticals ltd - didanosine - chewable tablet - 25mg
perfalgan 1g/100ml solution for infusion vials
bristol-myers squibb pharmaceuticals ltd - paracetamol - solution for infusion - 10mg/1ml
perfalgan 500mg/50ml solution for infusion vials
bristol-myers squibb pharmaceuticals ltd - paracetamol - solution for infusion - 10mg/1ml
yervoy
bristol-myers squibb (nz) limited - ipilimumab 5 mg/ml; - concentrate for injection - 200 mg/40 ml - active: ipilimumab 5 mg/ml excipient: hydrochloric acid mannitol nitrogen pentetic acid polysorbate 80 sodium chloride sodium hydroxide trometamol hydrochloride water for injection - yervoy, as monotherapy, is indicated for the treatment of patients with unresectable or metastatic melanoma in adults, 18 years of age or older. yervoy, in combination with opdivo (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic disease melanoma.